- Home
- SOS vs NRSN Comparison
SOS vs NRSN Comparison
Compare SOS & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOS
- NRSN
- Stock Information
- Founded
- SOS 2004
- NRSN 2017
- Country
- SOS China
- NRSN Israel
- Employees
- SOS N/A
- NRSN N/A
- Industry
- SOS Finance: Consumer Services
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- SOS Finance
- NRSN Health Care
- Exchange
- SOS Nasdaq
- NRSN Nasdaq
- Market Cap
- SOS 21.7M
- NRSN 26.0M
- IPO Year
- SOS 2017
- NRSN 2021
- Fundamental
- Price
- SOS $4.38
- NRSN $0.91
- Analyst Decision
- SOS
- NRSN Hold
- Analyst Count
- SOS 0
- NRSN 1
- Target Price
- SOS N/A
- NRSN N/A
- AVG Volume (30 Days)
- SOS 9.4K
- NRSN 172.3K
- Earning Date
- SOS 01-01-0001
- NRSN 04-08-2025
- Dividend Yield
- SOS N/A
- NRSN N/A
- EPS Growth
- SOS N/A
- NRSN N/A
- EPS
- SOS N/A
- NRSN N/A
- Revenue
- SOS $111,124,000.00
- NRSN N/A
- Revenue This Year
- SOS N/A
- NRSN N/A
- Revenue Next Year
- SOS N/A
- NRSN N/A
- P/E Ratio
- SOS N/A
- NRSN N/A
- Revenue Growth
- SOS N/A
- NRSN N/A
- 52 Week Low
- SOS $4.30
- NRSN $0.51
- 52 Week High
- SOS $22.35
- NRSN $2.25
- Technical
- Relative Strength Index (RSI)
- SOS 33.78
- NRSN 29.02
- Support Level
- SOS $4.30
- NRSN $0.89
- Resistance Level
- SOS $5.00
- NRSN $1.13
- Average True Range (ATR)
- SOS 0.25
- NRSN 0.08
- MACD
- SOS 0.02
- NRSN -0.02
- Stochastic Oscillator
- SOS 9.24
- NRSN 4.40
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of big data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other service. The company has has three reporting segments: Commodity trading, Cryptocurrency mining and Others. Key revenue is generated from Commodity trading.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.